Tuesday, November 27th, 2012
Stephan: For several years now I have been writing about the corruption of the medical literature in the service of the Illness Profit System (See An Appraisal of The Illness Profit System http://www.explorejournal.com/article/S1550-8307%2810%2900291-0/fulltext). This trend has received very little attention in the corporate media (this is the first piece I have seen in a major newspaper in months) but it has very dangerous implications for you and your family, and is specifically designed to mislead your local doctor, who guides his practice based on the papers in medical journals.
For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup.
The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.
‘We now have clear evidence from a large international study that the initial use of [Avandia] is more effective than standard therapies,
